Fingerprint Testing of Traditional Chinese Medicine Injections: Chromatographic Profiling and Qualit

Fingerprint testing of Traditional Chinese Medicine (TCM) injections is an essential quality control technique that characterizes the complete chemical profile of herbal injectable products through advanced chromatographic analysis. By establishing reference fingerprints and evaluating batch-to-batch similarity, this testing approach ensures consistency, safety, and efficacy throughout the entire manufacturing chain—from raw herbs to finished injectable formulations. This article provides a comprehensive technical overview of fingerprint testing services for TCM injections, covering sample types, testing items, analytical methods, and regulatory applications.

Technical Overview

Traditional Chinese Medicine injections represent one of the most technically demanding dosage forms in pharmaceutical manufacturing. Unlike synthetic chemical drugs with a single defined active ingredient, TCM injections contain hundreds of chemical constituents derived from one or multiple herbal sources. Conventional quality control methods that target only a few marker compounds are insufficient to guarantee overall product quality. Chromatographic fingerprint testing addresses this challenge by providing a holistic, multi-component characterization of the product's chemical composition.

A chromatographic fingerprint is a characteristic chromatographic profile obtained under strictly standardized analytical conditions. It functions as a "chemical identity card" for the product, displaying the relative retention times and relative peak areas of all detectable constituents. Regulatory authorities, including the National Medical Products Administration (NMPA) of China, require fingerprint data for registration, batch release, and post-market surveillance of TCM injections. The technical requirements are primarily governed by the Chinese Pharmacopoeia and the "Technical Requirements for Fingerprint Research of Traditional Chinese Medicine Injections," which define criteria for reference fingerprint establishment, similarity calculation, and method validation.

Fingerprint testing typically follows a whole-process control strategy: fingerprints are developed not only for the finished injection but also for the herbal raw materials and manufacturing intermediates. This enables manufacturers to trace quality variation across every production stage, identify critical process points, and build a comprehensive quality traceability system.

Testing Samples

Fingerprint testing covers samples from all stages of the TCM injection production chain. Submitting samples from each stage allows full-process quality correlation analysis and root-cause investigation when deviations occur.

Herbal Raw Materials and Decoction Pieces

Crude herbal drugs and processed decoction pieces serve as the starting point of the manufacturing chain. Fingerprint analysis of raw materials verifies botanical authenticity, detects adulteration or substitution, and evaluates the impact of origin, harvest season, and drying conditions on chemical composition. Multiple batches from different suppliers and origins are analyzed to establish a robust raw material fingerprint library.

Manufacturing Intermediates

Intermediates include water or ethanol extracts, refined extracts after processes such as alcohol precipitation, acid-base extraction, resin adsorption, or membrane filtration, and concentrated slurries. Intermediate fingerprints reveal how each unit operation affects the chemical profile, supporting process optimization and control strategy development.

Finished Injection Products

Finished products cover small-volume injections, large-volume infusions, and lyophilized powders for injection. Testing may be performed on the formulated product, the drug substance before final sterilization, and stability samples stored under accelerated and long-term conditions. Placebo and excipient solutions are also analyzed to distinguish matrix-derived peaks from herbal constituents.

Reference Materials

Reference substances include chemically defined markers (pharmacopoeial reference compounds), reference extracts, and laboratory-prepared reference fingerprint samples constructed from multiple qualified batches. These materials anchor retention time alignment and peak assignment during data evaluation.

Testing Items

The core testing program for TCM injection fingerprints encompasses the following items, each with defined acceptance criteria and deliverables:

• Chromatographic fingerprint acquisition: Generation of a full-profile chromatogram covering the entire elution window, with typical run times of 60–120 minutes for HPLC methods.
• Reference fingerprint establishment: Construction of a consensus reference fingerprint (RFP) from at least 10 consecutive qualified batches using median or mean calculation algorithms.
• Common peak designation: Identification and numbering of shared peaks present in all batches, with calculation of relative retention times (RRT) and relative peak areas (RPA) against an internal reference peak.
• Similarity evaluation: Quantitative calculation of similarity coefficients between each sample fingerprint and the reference fingerprint, typically using the cosine angle or correlation coefficient algorithm. Regulatory expectations generally require similarity values of not less than 0.90 for finished products.
• Characteristic peak identification: Assignment of major peaks to specific chemical constituents through comparison with reference substances and mass spectrometric confirmation, including reporting of the percentage of identified peak area relative to total peak area.
• Peak area ratio and non-shared peak analysis: Evaluation of the ratio of non-shared or deviating peak area to total peak area, with limits on abnormal peaks that may indicate contamination or degradation.
• Method validation: Verification of precision (instrument and injection repeatability), reproducibility (inter-analyst and inter-day), sample solution stability, and robustness across deliberate variations in chromatographic parameters.
• Stability fingerprint comparison: Comparative fingerprint analysis of stability samples against time-zero profiles to detect degradation trends.

Testing Methods

Method selection depends on the chemical nature of the herbal constituents. A combination of orthogonal chromatographic techniques is frequently employed to maximize the number of resolved and characterized components.

High Performance Liquid Chromatography (HPLC-DAD)

HPLC coupled with diode-array detection is the most widely used platform for TCM injection fingerprinting, particularly for phenolic acids, flavonoids, alkaloids, saponins, and anthraquinones. Typical configurations employ reversed-phase C18 columns (250 mm × 4.6 mm, 5 μm), gradient elution with acidified water–acetonitrile or water–methanol mobile phases, and detection wavelengths selected from full-spectral DAD scanning (commonly 200–400 nm). The Chinese Pharmacopoeia Chromatographic Fingerprint Evaluation System software is used for automated peak matching, calibration, and similarity calculation.

Ultra High Performance Liquid Chromatography (UPLC/UHPLC)

UPLC methods using sub-2 μm particle columns achieve higher resolution, shorter analysis time, and improved sensitivity. UPLC fingerprints are increasingly accepted for new product registrations and are particularly valuable for complex multi-herbal formulations requiring enhanced peak capacity.

Gas Chromatography (GC and GC-MS)

GC fingerprints are applied to volatile constituents such as essential oil components, sesquiterpenes, and residual extraction solvents. Direct injection, headspace sampling, or derivatization protocols are selected according to sample volatility. GC-MS confirmation enables structural identification of volatile marker compounds.

Hyphenated Mass Spectrometry (LC-MS/MS)

Liquid chromatography tandem mass spectrometry is used for peak identification and trace-level constituent characterization. High-resolution mass spectrometry (Q-TOF or Orbitrap) provides accurate mass measurement and fragment ion data for tentative structural elucidation of unknown peaks, supporting toxic constituent screening (such as aristolochic acids or pyrrolizidine alkalines) and forced-degradation studies.

Capillary Electrophoresis and Other Complementary Techniques

Capillary electrophoresis (CE), thin-layer chromatography (TLC) densitometry profiles, and infrared (IR) spectroscopic fingerprints may serve as supplementary orthogonal methods when polar or ionic constituents are poorly retained by conventional HPLC conditions.

Data Processing and Evaluation Workflow

The standard workflow comprises chromatographic acquisition, retention time correction using multi-point calibration, peak alignment and matching against the reference fingerprint, calculation of relative parameters, statistical similarity computation, and final report generation. Multivariate statistical tools such as principal component analysis (PCA) and hierarchical clustering are applied to visualize batch distribution and detect outlier trends beyond simple similarity coefficients.

Applications

Fingerprint testing of TCM injections supports a broad range of pharmaceutical development and regulatory activities:

• New drug registration and market approval: Submission of fingerprint research data as an integral component of the CMC (Chemistry, Manufacturing, and Controls) dossier required by the NMPA for TCM injection registration and post-approval changes.
• Batch release and routine quality control: Incorporation of similarity criteria (≥0.90) into in-house release specifications, providing a sensitive indicator of manufacturing consistency.
• Raw material supplier qualification: Evaluation and periodic re-qualification of herbal suppliers based on fingerprint comparison and multivariate statistical analysis.
• Manufacturing process validation and transfer: Demonstration that scale-up, site transfer, or process modification preserves the chemical profile within established similarity limits.
• Stability and shelf-life studies: Monitoring of chemical profile changes during accelerated and long-term storage to support expiry date assignment and storage condition justification.
• Adverse event investigation: Comparative fingerprint analysis of retained samples from suspect batches against the reference library to identify quality deviations potentially linked to clinical adverse reactions.
• Consistency evaluation of marketed products: Support for quality consistency studies required under post-marketing reassessment programs for TCM injections.
• Herbal origin and authenticity research: Discrimination of geographical origins and cultivation varieties through chemometric classification of fingerprint datasets.

FAQ

What similarity threshold is required for a passing fingerprint result?

For finished TCM injection products, regulatory guidance and pharmacopoeial practice generally require a similarity coefficient of not less than 0.90 when calculated against the reference fingerprint using the official evaluation software. For raw materials and intermediates, thresholds may be adjusted based on process research data, but values below 0.85 typically indicate significant deviation requiring investigation.

How many batches are needed to establish a reference fingerprint?

A minimum of 10 consecutive qualified batches is the customary requirement for constructing a representative reference fingerprint for registration purposes. For products with limited production history, a provisional reference may be established from fewer batches and updated as additional data accumulate.

Which analytical technique should be chosen for a specific injection?

Method selection is driven by the chemical profile of the herbal source. Non-volatile polyphenols, alkaloids, and saponins are best profiled by HPLC-DAD or UPLC; volatile constituents require GC or GC-MS; and formulations with unknown or trace-level critical components benefit from LC-MS/MS characterization. A combined fingerprint strategy using two orthogonal techniques is recommended for complex multi-herbal injections.

What is the typical testing cycle and required sample quantity?

A complete fingerprint testing program, including method development or transfer, validation, and similarity evaluation across multiple batches, generally requires 10 to 20 working days depending on method complexity. Sample requirements are typically 10–20 mL of injection solution or the equivalent amount of extract per batch, along with available reference substances.

Can fingerprint testing replace assay testing for marker compounds?

No. Fingerprint testing and quantitative assay testing are complementary. Fingerprint analysis provides holistic profile consistency, while quantitative assays verify the exact content of key active or marker constituents. A complete quality control system for TCM injections incorporates both approaches alongside safety tests such as pyrogen, allergenic substance, hemolysis, and abnormal toxicity testing.

Are fingerprints stable across different laboratories and instruments?

Fingerprints are instrument-dependent in absolute retention times; therefore, methods specify relative retention times against a designated reference peak, and inter-laboratory comparability is achieved through validated method transfer, system suitability testing, and the use of standard reference fingerprints. Robustness validation across column lots and instrument platforms is an essential component of the method lifecycle.